Publications by authors named "Marcello Pasquini"
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.
Meera Mohan Anai Kothari Nathaniel Verhagen Aditya Shreenivas Sabarinath Venniyil Radhakrishnan Marcello Pasquini
Bone Marrow Transplant
January 2024
Background: In the novel and pre-novel agent era, high-dose therapy, followed by autologous hematopoietic cell transplantation (AHCT), has been shown to prolong survival in patients with multiple myeloma (MM) in randomized trials. However, these trials only included patients aged ≤ 65 years. Given that the median age at diagnosis is 66 years, it is important to know the outcomes of AHCT in older patients.
View Article and Find Full Text PDF